1[1]Lesavre P . Antineutrophil cytoplasmic autoantibodies: Antigen specificity [J]. Am J Kidney Dis,1991;18:159.
2[2]Ligthart GJ,Coiberand JX,Fournier C,et al.Admission criteria for immunogerontological studies in man: The SENIEUR protocol [J]. Mech Ageing Deu,1984; 28:47-55.
3[3]Hagen EC, Andrassy KE,Czernok E,et al. The value of indirect immunofluorescence and solid phase techniques for ANCA detection.A report on the first phase of an international cooperative study on the standardization of ANCA assays [J].J Immunol Methods,1993;159:1-16.
4[4]Gross WL , Csernok E ,Helmchem U,et al. Antineutrophil cytop-lasmic autoantibodies autoantigens and systemic vasculitis [J] .APMIS,1995;103:81-97.
6[6]Savige J, Davies D, Falk RJ,et al.Antineutrophil cytoplasmic anti-bodies and associated diseases: A review of the clinical and laboratory features [J]. Kidney Inter, 2000;57: 846-862.
7[7]Bajuma IM, Hagen EC, Hermans J,et al.Kidney biopsy as a predi-ctor forrenal outcome in ANCA-associated narcotizing glomerulon-ephritis [J]. Kidney Inter, 1999;56: 1751-1758.
8[8]NilesJ L, Bottinger EP, Sourina GR,et al.The syndrome of lung hemorrhage and nephritis is usually an ANCA-assorted condition [J]. Arch Inter Med,1996;156: 440-445.
